Genmab | GEN - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Almirall EUR 337.77M 14.83M 2025-12
Amarin USD 143.56M 12.5M 2026-06
Amgen USD 12.04B 2.91B 2026-03
argenx SE USD 4.3B 808.71M 2026-03
AstraZeneca USD 7.56B 1.85B 2026-03
Bayer EUR 6.67B 774M 2025-12
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Demant DKK 1.33B 188M 2025-12
Exelixis USD 226.15M 256.34M 2026-03
Fresenius Medical Care EUR 1.24B 343.37M 2026-03
Genmab DKK 1.72B 46M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
GN Store Nord DKK 1.12B 352M 2025-12
GRIFOLS EUR 702M 99M 2026-03
Hikma Pharmaceutical USD 236M 48M 2025-06
Insmed USD 582.19M 71.74M 2026-03
Lakefront Biotherapeutics EUR 66.8M 21.06M 2026-03
Lonza CHF 719M 188M 2025-12
Merck EUR 2.33B 77M 2025-12
Novartis USD 7.62B 739M 2026-06
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
UCB EUR 1.57B 1.14B 2024-12